Commercialization Intake

Begin your custom roadmap

A nine-section assessment. “Unknown” is an acceptable answer anywhere — identifying uncertainty is part of the process.

Advisor · 1099Reps

You're about to save weeks of back-and-forth.

1099Reps has guided pre-510(k) medtech companies through every stage of commercialization — from regulatory posture to their first reordering accounts. This questionnaire is the same one Traves Brady uses in every first engagement. Answer what you know; unknowns are expected and valued.

Companies that complete this intake receive a fully structured six-month roadmap — not a generic template, a custom one built from your actual situation.

Step 1 of 116-Month Complete — $75,000

Company & primary contact

23
Issued patents across US, CA, JP, AU, EU
35%
Commission on closed revenue — aligned incentives
48h
Roadmap draft returned after intake submission
$75K
Full six-month commercialization program
Working documents

Download the full strategy package